{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:49:48Z","timestamp":1782452988857,"version":"3.54.5"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection in children under the age of 5, worldwide. Maternal vaccination and monoclonal antibodies provide only temporary protection for young children. As antibody wanes, young children remain at risk for severe RSV disease, creating an unmet need for a direct childhood vaccine. We developed an intranasal (IN) subunit vaccine, comprised of a biotinylated nanoparticle and RSV prefusion protein DS-Cav1 (PreF-bNP) with a flexible \u201cplug-n-play\u201d design that enables dose optimization of antigen and adjuvants. In a preimmune RSV mouse model, immunization with intranasal PreF-bNP increased IL-12+ dendritic cells, generated Th1- polarized CD4 effector and tissue resident memory T cells (TRMs) and established antiviral CD8 TRMs in the lung. PreF-bNP-mediated antiviral responses correlated with complete RSV protection up to 8 weeks with reduced mucus production in the lungs. Together, the data presented demonstrate that intranasal PreF-bNP safely protects against RSV infection in young preimmune mice and should be further investigated for future clinical development.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1824823","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:44:52Z","timestamp":1782452692000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Intranasal delivery of a polymeric nanoparticle subunit vaccine for the induction of protective immunity against respiratory syncytial virus"],"prefix":"10.3389","volume":"17","author":[{"given":"Sarah M.","family":"Ostrowski","sequence":"first","affiliation":[{"name":"Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh","place":["Pittsburgh, PA, United States"]},{"name":"Center for Clinical Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Hartmeier","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, School of Pharmacy, Duquesne University","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline A.","family":"Lipp","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh","place":["Pittsburgh, PA, United States"]},{"name":"Center for Clinical Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Perkins","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, University of Pittsburgh","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Reed","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh","place":["Pittsburgh, PA, United States"]},{"name":"Center for Clinical Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyue","family":"Li","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, School of Pharmacy, Duquesne University","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson S.","family":"Meng","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, School of Pharmacy, Duquesne University","place":["Pittsburgh, PA, United States"]},{"name":"McGowan Institute for Regenerative Medicine, University of Pittsburgh","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry M.","family":"Empey","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh","place":["Pittsburgh, PA, United States"]},{"name":"Center for Clinical Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh","place":["Pittsburgh, PA, United States"]},{"name":"Department of Immunology, School of Medicine, University of Pittsburgh","place":["Pittsburgh, PA, United States"]},{"name":"Center for Vaccine Research, School of Medicine, University of Pittsburgh","place":["Pittsburgh, PA, United States"]},{"name":"Clinical and Translational Science Institute, School of Medicine, University of Pittsburgh","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/qco.0000000000000952","article-title":"The disease burden of respiratory syncytial virus in infants","volume":"36","author":"Munro","year":"2023","journal-title":"Curr Opin Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adz4626","article-title":"Maternal allergy and neonatal RSV infection synergize via FcR-mediated allergen uptake to promote the development of asthma in early life","volume":"10","author":"De Leeuw","year":"2025","journal-title":"Sci Immunol"},{"key":"B4","article-title":"Respiratory syncytial virus infection (RSV): immunizations to protect infants","year":"2025"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01829-6","article-title":"Nirsevimab: first approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2502984","article-title":"Clesrovimab for prevention of RSV disease in healthy infants","volume":"393","author":"Zar","year":"2025","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.12.007","article-title":"The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis","volume":"40","author":"Oguti","year":"2022","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00642-3","article-title":"Life-threatening infections due to live-attenuated vaccines: Early manifestations of inborn errors of immunity","volume":"39","author":"Poyhonen","year":"2019","journal-title":"J ClinImmunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2023.01.006","article-title":"Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies","volume":"13","author":"Hou","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nature04596","article-title":"Toll-dependent selection of microbial antigens for presentation by dendritic cells","volume":"440","author":"Blander","year":"2006","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.11.010","article-title":"PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration","volume":"29","author":"Stano","year":"2011","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201142361","article-title":"Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8(+) T-cell responses in melanoma patients","volume":"42","author":"Goldinger","year":"2012","journal-title":"Eur J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nature04267","article-title":"Control of B-cell responses by Toll-like receptors","volume":"438","author":"Pasare","year":"2005","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-021-00461-z","article-title":"Tissue resident memory T cells in the respiratory tract","volume":"15","author":"Zheng","year":"2022","journal-title":"Mucosal Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.2c00343","article-title":"Immune cells activating biotin-decorated PLGA protein carrier","volume":"19","author":"Hartmeier","year":"2022","journal-title":"Mol Pharm"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2023.08.048","article-title":"Modeling the kinetics of lymph node retention and exposure of a cargo protein delivered by biotin-functionalized nanoparticles","volume":"170","author":"Hartmeier","year":"2023","journal-title":"Acta Biomater"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.03.033","article-title":"Lymphatic distribution considerations for subunit vaccine design and development","volume":"42","author":"Hartmeier","year":"2024","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10856-009-3727-z","article-title":"Poly (lactic-co-glycolic acid) as a controlled release delivery device","volume":"20","author":"Lim","year":"2009","journal-title":"J Mater Sci - Mater Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.12.059","article-title":"Poly-(lactic-co-glycolic-acid)-based particulate vaccines: Particle uptake by dendritic cells is a key parameter for immune activation","volume":"33","author":"Silva","year":"2015","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101762","article-title":"Targeting dendritic cells to advance cross-presentation and vaccination outcomes","volume":"68","author":"Macri","year":"2023","journal-title":"Semin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0264-410x(02)00435-8","article-title":"Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres","volume":"21","author":"Gutierro","year":"2002","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1104264108","article-title":"Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination","volume":"108","author":"Nembrini","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1038\/s41467-025-59353-6","article-title":"An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models","volume":"16","author":"Anthi","year":"2025","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109400","article-title":"A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters","volume":"36","author":"Bricker","year":"2021","journal-title":"Cell Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbrc.2022.06.015","article-title":"Comparison of the efficacy and safety of different immunization routes induced by human respiratory syncytial virus F protein with CpG adjuvant in mice","volume":"618","author":"Li","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040499","article-title":"Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection","volume":"7","author":"Empey","year":"2012","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jconrel.2016.11.016","article-title":"The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis","volume":"245","author":"Jain","year":"2017","journal-title":"J Controlled Release"},{"key":"B30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.addr.2004.09.003","article-title":"Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens","volume":"57","author":"Jiang","year":"2005","journal-title":"Adv Drug Delivery Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.05.005","article-title":"Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles","volume":"22","author":"Mollenkopf","year":"2004","journal-title":"Vaccine"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164789","article-title":"Stability characterization of a vaccine antigen based on the respiratory syncytial virus fusion glycoprotein","volume":"11","author":"Flynn","year":"2016","journal-title":"PloS One"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100363","article-title":"Duration of antigen availability influences the expansion and memory differentiation of T cells","volume":"187","author":"Blair","year":"2011","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1206026","article-title":"Exacerbated lung inflammation following secondary RSV exposure is CD4+ T cell-dependent and is not mitigated in infant BALB\/c mice born to PreF-vaccinated dams","volume":"14","author":"Kosanovich","year":"2023","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1025341","article-title":"Prior respiratory syncytial virus infection reduces vaccine-mediated Th2-skewed immunity, but retains enhanced RSV F-specific CD8 T cell responses elicited by a Th1-skewing vaccine formulation","volume":"13","author":"Eichinger","year":"2022","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1112648109","article-title":"Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction","volume":"109","author":"Moon","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-020-0309-3","article-title":"Long-term maintenance of lung resident memory T cells is mediated by persistent antigen","volume":"14","author":"Uddback","year":"2021","journal-title":"Mucosal Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.mucimm.2023.05.012","article-title":"Increased innate immune activation induces protective RSV-specific lung-resident memory T cells in neonatal mice","volume":"16","author":"Malloy","year":"2023","journal-title":"Mucosal Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1038\/ncomms5821","article-title":"Resident CD4+ T cells accumulate in lymphoid organs after prolonged antigen exposure","volume":"5","author":"Ugur","year":"2014","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/cells13242073","article-title":"Recent technologies on 2D and 3D imaging flow cytometry","volume":"13","author":"Ugawa","year":"2024","journal-title":"Cells"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.1.9611050","article-title":"Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response","volume":"156","author":"Roman","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01297.x","article-title":"Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry","volume":"121","author":"Bendelja","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J Exp Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01673","article-title":"Prefusion RSV F immunization elicits Th2-mediated lung pathology in mice when formulated with a Th2 (but not a Th1\/Th2-balanced) adjuvant despite complete viral protection","volume":"11","author":"Eichinger","year":"2020","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01502-22","article-title":"Long-lasting protection induced by a polyanhydride nanovaccine against respiratory syncytial virus in an outbred mouse model","volume":"96","author":"Stephens","year":"2022","journal-title":"J Virol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186184","article-title":"Immunization with a mucosal, post-fusion F\/G protein-based polyanhydride nanovaccine protects neonatal calves against BRSV infection","volume":"14","author":"Maina","year":"2023","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.023","article-title":"Formulation of the prefusion RSV F protein with a Th1\/Th2-balanced adjuvant provides complete protection without Th2-skewed immunity in RSV-experienced young mice","volume":"38","author":"Kosanovich","year":"2020","journal-title":"Vaccine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1824823\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:44:53Z","timestamp":1782452693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1824823\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2026.1824823"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1824823","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"1824823"}}